Voya Financial Advisors Inc. Sells 186 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Voya Financial Advisors Inc. decreased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 11.2% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,475 shares of the medical equipment provider’s stock after selling 186 shares during the quarter. Voya Financial Advisors Inc.’s holdings in Intuitive Surgical were worth $707,000 as of its most recent SEC filing.

Several other large investors also recently added to or reduced their stakes in the stock. Ridgewood Investments LLC purchased a new position in shares of Intuitive Surgical during the second quarter valued at $26,000. Godsey & Gibb Inc. grew its holdings in Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after acquiring an additional 35 shares in the last quarter. LGT Financial Advisors LLC increased its position in Intuitive Surgical by 415.4% during the 2nd quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock valued at $30,000 after purchasing an additional 54 shares during the period. MidAtlantic Capital Management Inc. bought a new stake in shares of Intuitive Surgical in the 3rd quarter valued at about $33,000. Finally, Capital Performance Advisors LLP purchased a new stake in shares of Intuitive Surgical in the 3rd quarter worth approximately $38,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of analysts have weighed in on ISRG shares. Morgan Stanley upgraded Intuitive Surgical from an “equal weight” rating to an “overweight” rating and upped their target price for the stock from $522.00 to $650.00 in a report on Monday. Oppenheimer reaffirmed a “market perform” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Royal Bank of Canada boosted their target price on shares of Intuitive Surgical from $525.00 to $555.00 and gave the stock an “outperform” rating in a report on Friday, October 18th. Mizuho raised their price target on shares of Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. Finally, Raymond James increased their target price on shares of Intuitive Surgical from $500.00 to $540.00 and gave the company an “outperform” rating in a research report on Monday, October 14th. One research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $541.33.

Intuitive Surgical Trading Down 0.4 %

ISRG opened at $547.65 on Friday. The firm has a 50 day moving average of $514.78 and a two-hundred day moving average of $472.60. The firm has a market capitalization of $195.06 billion, a PE ratio of 88.05, a P/E/G ratio of 5.33 and a beta of 1.38. Intuitive Surgical, Inc. has a 12-month low of $307.72 and a 12-month high of $552.08.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.24 by $0.32. The company had revenue of $2.04 billion during the quarter, compared to the consensus estimate of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. As a group, analysts predict that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, CFO Jamie Samath sold 188 shares of the stock in a transaction that occurred on Friday, November 29th. The stock was sold at an average price of $539.00, for a total transaction of $101,332.00. Following the transaction, the chief financial officer now owns 8,757 shares in the company, valued at approximately $4,720,023. This represents a 2.10 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, General Counsel Gary Loeb sold 300 shares of the business’s stock in a transaction that occurred on Monday, September 9th. The shares were sold at an average price of $475.00, for a total value of $142,500.00. Following the completion of the sale, the general counsel now owns 1,595 shares of the company’s stock, valued at $757,625. This trade represents a 15.83 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 51,023 shares of company stock worth $26,384,247 over the last quarter. 0.90% of the stock is currently owned by insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.